Pyrazolopyridines with potent activity against herpesviruses: Effects of C5 substituents on antiviral activity

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 3, 2008, Pages 1157-1161

  Gudmundsson, Kristjan S ^a   Johns, Brian A ^a   Allen, Scott H ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Antiviral; Herpes viruses; HSV; Pyrazolopyridine; SAR

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; PYRIDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; HERPES VIRUS; IN VITRO STUDY; NONHUMAN; SUBSTITUTION REACTION;

ACYCLOVIR; ANTIVIRAL AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; HERPESVIRIDAE; HUMANS; MOLECULAR STRUCTURE; PYRAZOLES; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 38749094459     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.11.120     Document Type: Article

References (28)

1. Roizman, B.; Pellett, P. E. In Fields Virology; Knipe, D. M.; Howley, P. M., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, 2001; Vol. 2, 2381.
2. Kleymann G. Expert Opin. Investig. Drugs 12 (2003) 165-183
3. Corey L., and Spear P. New Engl. J. Med. 314 (1986) 686
4. Corey L., and Handsfield H.H. J. Am. Med. Assoc. 283 (2000) 791
5. Moomaw M.D., Cornea P., Rathbun R.C., and Wendel K.A. Expert Rev. Anti-infect. Ther. 1 (2003) 283
6. Firestine S.M. Expert Opin. Ther. Patents 14 (2004) 1139
7. Elion G.B., Furman P.A., Fyfe J.A., De Miranda P., Beauchamp L., and Schaeffer H.J. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5716
8. Perry C.M., and Faulds D. Drugs 52 (1996) 754
9. Jarvest R.L., Sutton D., and Vere Hodge R.A. Pharm. Biotechnol. 11 (1998) 313
10. Garland S.M. Curr. Opin. Infect. Dis. 16 (2003) 85
11. Taff J. Curr. Opin. Investig. Drugs 4 (2003) 214
12. Spruance S.L., Tyring S.K., Smith M.H., and Meng T.C. J. Infect. Dis. 184 (2001) 196
13. Oien N.L., Brideau R.J., Hopkins T.A., et al. Antimicrob. Agents Chemother. 46 (2002) 724
14. Wathen M.W. Rev. Med. Virol. 12 (2002) 167
15. Jurk M., Heil R., Vollmer J., et al. Nat. Immunol. 3 (2002) 499
16. Crute J.J., Grygon C.A., Hargrave K.D., Simoneau B., Faucher A.-M., Bolger G., Kibler P., Liuzzi M., and Cordingley M.G. Nat. Med. 8 (2002) 386
17. Kleymann G., Fischer R., Betz U.A.K., Hendrix M., Bender W., Schneider U., Handke G., Eckenberg P., et al. Nat. Med. 8 (2002) 392
18. Naesens L., and De Clercq E. Herpes 8 (2001) 12
19. Villerreal E.C. Prog. Drug Res. 56 (2001) 77
20. Snoeck R., and De Clercq E. Curr. Opin. Infect. Dis. 15 (2002) 49
21. Johns B.A., Gudmundsson K.S., Turner E.M., Allen S.H., Jung D.K., Sexton C.J., Boyd Jr. F.L., and Peel M.R. Tetrahedron 59 (2003) 9001
22. Gudmundsson K.S., Johns B.A., Wang Z., Turner E.M., Allen S.H., Freemen G.A., Boyd Jr. F.L., Sexton C.J., Selleseth D.W., Moniri K.R., and Creech K.L. Bioorg. Med. Chem. 13 (2005) 5346
23. Allen S.H., Johns B.A., Gudmundson K.S., Freeman G.A., Boyd Jr. F.L., Sexton C.J., Selleseth D.W., Creech K.L., and Moniri K.R. Bioorg. Med. Chem. 14 (2006) 944
24. Johns B.A., Gudmundsson K.S., Turner E.M., Allen S., Samano V.A., Ray J.A., Freeman G.A., Boyd Jr. F.L., Sexton C.J., Selleseth D.W., Creech K.L., and Moniri K.R. Bioorg. Med. Chem. 13 (2005) 2397
25. Johns B.A., Gudmundsson K.S., and Allen S. Bioorg. Med. Chem. Lett. 17 (2007) 2858
26. Wolfe J.P., and Buchwald S.L. J. Org. Chem. 65 (2000) 1144
27. Finkelstein B.L. J. Org. Chem. 57 (1992) 5538
28. Aboul-Fadl T., Lober S., and Gmeiner P. Synthesis (2000) 1727